Wyeth Wins Los Angeles Diet Drug Trial
"We are pleased with the verdicts and believe they were supported by the facts. Wyeth will continue to vigorously defend itself in this litigation," says Lawrence V. Stein, Senior Vice President and General Counsel, Wyeth.
The trial began on October 21, 2005 before The Honorable Daniel S. Pratt. The plaintiffs alleged heart valve injury from the use of the diet drug Pondimin, a drug once marketed by Wyeth. In accordance with procedures established by the Court, three of these four plaintiffs were selected for this trial group by plaintiffs' counsel. The plaintiffs were represented by the firms of Williams & Bailey and Blizzard, McCarthy & Nabers of Houston, Texas.
Other news from the department politics & laws
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.